The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Monday, December 25, 2017
AuroMedics Pharma is voluntarily recalling one lot of Pantoprazole Sodium for Injection 40 mg per vial, to the hospital level.
read more
Thursday, December 28, 2017
Integrity Applications has entered into an exclusive distribution agreement with MediReva for the GlucoTrack in the Netherlands.
read more
Friday, December 29, 2017
Twice a year the federal government publishes the Unified Agenda which provides the American public with insight into regulations under development or...
read more
Thursday, January 11, 2018
Baxter announced a distribution agreement for the U.S. launch of the Arisure Closed System Transfer device.
read more
Fresenius Kabi has announced the availability in the United States of Bortezomib for Injection.
read more
SFC Fluidics announced a new Industry Development and Discovery Partnership supported by JDRF, a global organization funding type 1 diabetes (T1D) ...
read more
Tuesday, January 23, 2018
OraPharma has begun promoting SPRIX Nasal Spray to more than 9,000 dentists and oral surgeons across the United States.
read more
Thursday, January 25, 2018
Hologic announced that the FDA has granted PMA approval for the Aptima HBV Quant Assay for quantitation of hepatitis B viral load on the fully ...
read more
Tuesday, February 06, 2018
PharmaJet announced Vaccibody AS is expanding their human clinical trial for the study of a vaccine to treat HPV disease using the PharmaJet Stratis ...
read more
Monday, February 12, 2018
Teva announced QVAR RediHaler Inhalation Aerosol is now commercially available to patients in both 40 mcg and 80 mcg strengths by prescription in the ...
read more
Wednesday, February 21, 2018
Biohaven has entered into an exclusive worldwide license agreement with Catalent to provide Zydis ODT for the development of Biohaven's lead CGRP ...
read more
Tuesday, February 27, 2018
Amgen announced the CHMP of the EMA has issued a positive opinion recommending a label variation for Neulasta to include the Neulasta Onpro Kit.
read more
Ontario has become the first Canadian province to provide access to NARCAN Nasal Spray free of charge through pharmacies as part of its Ontario ...
read more
PharmaJet announced the reporting of positive interim results from the Phase 1 clinical trial conducted by the US Army Medical Research Institute of ...
read more
Wednesday, March 21, 2018
AOBiome Therapeutics announced clinical findings from Part 1 of a Phase 1b/2a clinical trial of the company's first-in-class Ammonia Oxidizing ...
read more